Oleksandr Sverdlov

Avery McIntosh, a statistician at Pfizer specializing in gene therapy, and Oleksandr Sverdlov from Novartis, focusing on neuroscience, share their insights into the innovative world of gene therapy. They discuss the evolution and breakthroughs in the field, like CRISPR technology, while addressing the ethical challenges of clinical trials. Their experiences highlight the important role statisticians play in navigating regulatory demands and advancing treatment solutions. Listeners will appreciate the blend of technical expertise and compelling storytelling.